Results 181 to 190 of about 282,693 (304)

Some practical issues about HLA-A29 in birdshot retinochoroiditis

open access: yesJournal of Ophthalmic Inflammation and Infection, 2023
Ioannis Papasavvas   +2 more
doaj   +1 more source

Evaluation of Retinal Arteriosclerotic Changes as a Risk factor of Cerebral Vascular Disease

open access: bronze, 1987
宮川 昭平   +6 more
openalex   +2 more sources

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

A Case of Hereditary Hemorrhagic Telangiectasia (Rendu‐Osler‐Weber's Disease) with Dystrophic Calcinosis Cutis and Retinal Lesions [PDF]

open access: bronze, 2002
Hideto Takahama   +4 more
openalex   +1 more source

Rare pediatric retinal diseases: A review. [PDF]

open access: yesIndian J Ophthalmol
Vinekar A   +11 more
europepmc   +1 more source

Proteomics approach identifies aqueous humor biomarkers in retinal diseases. [PDF]

open access: yesCommun Med (Lond)
Huang K   +11 more
europepmc   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Home - About - Disclaimer - Privacy